FDA OKs New Therapy for Some Hemophilia Patients - NBC 5 Dallas-Fort Worth
National & International News
The day’s top national and international news

FDA OKs New Therapy for Some Hemophilia Patients

Genentech, the drug's developer, says the list price will be about $482,000 for the first year and slightly less after that

    processing...

    NEWSLETTERS

    FDA OKs New Therapy for Some Hemophilia Patients
    AP/Genentech, Inc.
    This photo provided by Genentech, Inc. shows a package of the drug Hemlibra. On Thursday, Nov. 16, 2017, the Food and Drug Administration approved Hemlibra, the first new treatment in nearly two decades to prevent internal bleeding in certain patients with hemophilia, an inherited blood-clotting disorder.

    U.S. regulators have approved the first new treatment in nearly two decades to prevent internal bleeding in certain patients with hemophilia, an inherited blood-clotting disorder.

    The Food and Drug Administration on Thursday approved Hemlibra (hem-LEE'-bruh), a weekly injection for hemophilia A patients who have developed resistance to standard medicines.

    Genentech, the drug's developer, says the list price will be about $482,000 for the first year and slightly less after that.

    Genentech, a subsidiary of Swiss drugmaker Roche, says that's half the cost of the only other option for patients with this resistance. That treatment requires an IV drip several times a week.

    Colorado Man Charged With Five Counts of Murder in Deaths of Wife and Daughters

    [NATL] Colorado Man Charged With Five Counts of Murder in Deaths of Wife and Daughters

    Christopher Lee Watts was charged with five counts of murder Monday for the deaths of his wife Shanann Watts and their two daughters Bella and Celeste. Watts had initially pleaded publicly that his wife and daughters had gone missing. Their bodies were discovered on the property of the oil and natural gas company Watts worked for. The D.A. said that it's "too early" to discuss whether prosecutors would seek the death penalty.

    (Published Monday, Aug. 20, 2018)

    Hemophilia mostly affects males.